Metadoxine

美他多辛

Report date: 2023/03/23 14:11:00
NME

Base Information

Drug NameMetadoxine
Drug Alias NamePyridoxine pyrolateMetadoxilAbrixoneMG-01CIMDX
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin 2b (5-HT2b) receptor antagonists
TargetsSerotonin 2b (5-HT2b) receptor
Therapy Area/IndicationsAttention Deficit Disorder with HyperactivityAlcoholismFragile X Syndrome +[7] 
Global Approved IndicationsHepatitis, Alcoholic
Approved Indications in ChinaHepatitis, Alcoholic
Original Approved Country/TerritoryItaly
Original Approved Date1985/09/01
Country/TerritoryUnited StatesMexicoItaly +[6] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesLaboratori Baldacci SpaZhejiang Zhenyuan Pharmaceutical Co Ltd
Inactive CompaniesPharmakingHospital General De MexicoBrown University +[4] 
Active IndicationsHepatitis, Alcoholic
Inactive IndicationsAttention Deficit Disorder with HyperactivityAlcoholismFragile X Syndrome +[6] 

Other Information

ATC CodeA05
Related LinksWikipediaKEGG